| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eaf03c0818ab4fbfc2f0ffd284a7325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94b51d317764e2f4f1bbcb355b274c8b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B03C2201-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B03C2201-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-4915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-49 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B03C1-288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B03C1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B03C1-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B03C1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B03C1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B03C1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate |
2019-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ab4886ac225a248e9bca7b1a964721a |
| publicationDate |
2021-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210088594-A |
| titleOfInvention |
How to Create a Therapeutic Delivery Platform |
| abstract |
causing the target vesicle-like structure to react with and bind to the immunomagnetic particle; applying a magnetic field to capture the immunomagnetic particle/vesicle complex; further manipulation of the entrapped vesicles by surface modification with additional active moieties or internal loading of active agents; and an intact vesicle-like structure that can act as a delivery vehicle for therapeutic treatment, e.g., by photolytically cleaving the link between the particle and the engineered vesicle-like structure to release the engineered vesicle-like structure. A method of generating engineered exosomes and other vesicle-like biological targets in a microfluidic device comprising the step of releasing |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230026261-A |
| priorityDate |
2018-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |